Sophie Khanahmadi is named as a lobbyist on federal disclosure filings for 20 clients through Lmh Strategic Solutions. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PUBLIC STRATEGIES WASHINGTON OBO AMERICAN ASSOCIATION OF NURSE ANESTHESIOLOGY | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| UNIVERSITY OF LOUISVILLE HEALTH | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| PTC THERAPEUTICS, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | LMH STRATEGIC SOLUTIONS | Q3 2026 | Trade (domestic/foreign), Pharmacy |
| NEUROPACE, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| NATERA, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Pharmacy |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid, Health Issues |
| GLAXOSMITHKLINE LLC | LMH STRATEGIC SOLUTIONS | Q3 2026 | Pharmacy, Health Issues |
| ERISA INDUSTRY COMMITTEE (ERIC) | LMH STRATEGIC SOLUTIONS | Q3 2026 | Health Issues |
| ALNYLAM PHARMACEUTICALS, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| ALKERMES, INC. | LMH STRATEGIC SOLUTIONS | Q3 2026 | Medicare/Medicaid |
| SAVARA INC. | LMH STRATEGIC SOLUTIONS | Q2 2026 | Pharmacy, Health Issues |
| HARMONY BIOSCIENCES | LMH STRATEGIC SOLUTIONS | Q2 2026 | Health Issues |
| BICYCLE THERAPEUTICS | LMH STRATEGIC SOLUTIONS | Q1 2026 | Pharmacy, Health Issues |
| STEALTH BIOTHERAPEUTICS INC. | LMH STRATEGIC SOLUTIONS | Q1 2026 | Pharmacy, Health Issues |
| REGENXBIO INC. | LMH STRATEGIC SOLUTIONS | Q1 2026 | Pharmacy, Health Issues |
| IONIS PHARMACEUTICALS, INC. | LMH STRATEGIC SOLUTIONS | Q1 2026 | Health Issues |
| INCYTE CORPORATION | LMH STRATEGIC SOLUTIONS | Q1 2026 | Pharmacy, Health Issues |
| ARDELYX, INC. | LMH STRATEGIC SOLUTIONS | Q1 2026 | Pharmacy, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 20 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Sophie Khanahmadi. See the Capitol Clarity rankings and method.